Dr Reddy’s Laboratories

Dr Reddy’s to acquire Teva’s product portfolio for US Market

The portfolio being acquired is a mix of filed ANDAs pending approval and an approved ANDA. It also comprises complex generic products across diverse dosage forms

Dr Reddy’s Laboratories looks to acquire relevancy in the US; here’s how

DR Reddy’s Laboratories has entered into a definitive agreement with Israel-based Teva Pharmaceutical Industries and an affiliate...

Dr Reddy’s Laboratories looks to acquire relevancy in the US; here’s how

Dr Reddy’s to buy eight ANDAs in US for $350 mn

Dr Reddy's Laboratories has inked a pact with Teva Pharmaceutical and an affiliate of Allergan Plc to buy a portfolio of eight abbreviated new drug applications (ANDAs) in the US for $ 350 million (around Rs 2,300 crore) in c

Dr Reddy’s to buy eight ANDAs in US for $350 mn

US Consumer Commission seeks action against Dr Reddy Laboratories over packaging

The US Consumer Product Safety Commission (US CPSC) has approached the US Department of Justice seeking action against Dr Reddy's Laboratories in a 5-year old case involving packaging for five blister-packed prescription prod

US Consumer Commission seeks action against Dr Reddy Laboratories over packaging

Dr Reddy’s Labs shares plunge on packaging lapses charges

Dr Reddy's Laboratories shares plunged as much as 2.24 per cent on Thursday after reports that the US Consumer Product Safety Commission charges company for packaging lapses in at least five prescription drugs.

Dr Reddy’s Labs shares plunge on packaging lapses charges

Dr Reddy’s launches Sernivo spray in the US market

Sernivo Spray, a prescription topical steroid... indicated for the treatment of mild to moderate plaque psoriasisin patients 18 years of age or older...

Dr Reddy’s launches Sernivo spray in the US market

DRL enters branded consumer health arena through acquisition of six OTC brands

DRL will build upon the sales and marketing efforts for these brands and continue to focus on their expansion into existing and new market channels

Dr Reddy’s Laboratories buys 6 OTC brands from Ducere Pharma

Dr Reddy’s Laboratories has acquired a portfolio of over-the-counter (OTC) brands in the cough-and-cold, pain and dermatology categories.

Dr Reddy’s Laboratories buys 6 OTC brands from Ducere Pharma

Neutral rating on Dr Reddy’s; Weak Q4; sales down ~3% y-o-y

While long-term fundamentals remain intact, stock will stay range-bound in the near term

Neutral rating on Dr Reddy’s; Weak Q4; sales down ~3% y-o-y

Dr Reddy’s recalls 50k bottles of Ondansetron tabs in US

The ongoing recall was initiated on March 30, 2016

Dr Reddy’s recalls 50k bottles of Ondansetron tabs in US

Drug firm Dr Reddy's Laboratories is recalling over 50,000 bottles of Ondansetron tablets made at the company's Bachupally plant in India, on account of failed impurities/ degradation specifications.

Dr Reddy’s recalls 50k bottles of Ondansetron tabs in US

Dr Reddy’s shares fall nearly 3 per cent on weak Q4 results, Deutsche bank cuts target price

Dr Reddy's Laboratories shares fell 2.9 per cent in morning trade after its consolidated net profit declined by 85.6 per cent to Rs 74.6 crore for the March quarter on account of provisioning for outstanding receivables from

Dr Reddy’s shares fall nearly 3 per cent on weak Q4 results, Deutsche bank cuts target price

Dr Reddy’s clears Rs 1,569 crore buyback at Rs 3,500 per share

Dr Reddy's Laboratories on Tuesday informed bourses that its board has approved the buyback of 44.84 lakh equity shares with face value of Rs 5 each for aggregate amount not exceeding Rs 1,569 crore.

Dr Reddy’s clears Rs 1,569 crore buyback at Rs 3,500 per share

DRL in agreement with Eisai Co, Japan

Acquires rights to Investigational Anticancer Agent E7777 for US, Europe and certain emerging markets from Eisai

DRL in agreement with XenoPort

DRL will be granted exclusive US rights for the development and commercialisation of XenoPort’s clinical-stage oral new chemical entity, XP23829 Dr Reddy’s Laboratories (DRL) and XenoPort have entered into a license a

Advertisement
Income Tax Calculator, Budget 2019, How to Calculate Income Tax

 

Stock Market

Advertisement
Advertisement

TRENDING NOW

BUDGET 2019

Related Articles

FinancialExpress_1x1_Imp_Desktop